Cargando…
Anti-HBV Drugs: Progress, Unmet Needs, and New Hope
Approximately 240 million people worldwide are chronically infected with hepatitis B virus (HBV), which represents a significant challenge to public health. The current goal in treating chronic HBV infection is to block progression of HBV-related liver injury and inflammation to end-stage liver dise...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584298/ https://www.ncbi.nlm.nih.gov/pubmed/26389937 http://dx.doi.org/10.3390/v7092854 |